After acquiring AgraForm in 2024, Growmark continues to expand the St. Louis site with the construction of a biological crop input manufacturing plant. This announcement was made on Dec. 17.
“The scientific advancements in agricultural biologicals have introduced innovative methods for farmers to safeguard their plants and improve soil health with more sustainable options,” said Rod Wells, Growmark’s Senior Vice President of Strategy and Logistics. “It’s beneficial for both farmers and consumers when we enable farmers to grow healthier and stronger crops using these sustainable practices.”
Expected to be operational for production in 2027, the manufacturing facility will produce biostimulants, biopesticides, and biofertilizers. The company says it’s also building capacity to manufacture animal biological and waste treatment products.
Growmark says the demand for biological products, and therefore manufacturing of those products, has outpaced what companies are able to produce.
“As demand for biological products continues to grow across the ag industry, the construction of the new manufacturing plant will allow Growmark to provide high-quality biological products, made in the United States, to stakeholders throughout North America,” said Growmark Executive Vice President and Chief Operating Officer Brad Drake. “It also allows Growmark to influence another critical point in the ag value chain to better serve its members and customers.”
